Hajime Fujita Becomes CEO at Daiya Foods

Daiya Foods has appointed Hajime Fujita as its new Chief Executive Officer. In this role, Mr. Hajime Fujita will be responsible for overseeing global operations across North America, spearheading the brand’s international expansion efforts,” the company announced.

Mr. Fujita joins Daiya from Otsuka Pharmaceuticals, the parent company, where he previously served as Vice President. Notably, he played a pivotal role in Otsuka’s acquisition of Daiya in 2017. During his tenure from 2018 to 2021, he held the position of Director at Daiya and also served as a vice president on Daiya’s board at Otsuka America. Before joining Daiya, Mr. Fujita held the position of vice president of sales at Sanyo Manufacturing Corp.

Additionally, within Daiya Foods, Melanie Domer has been promoted from Chief Marketing Officer to Chief Commercial Officer, assuming responsibility for both marketing and sales. Prior to joining Daiya, Ms. Domer held various leadership roles at SC Johnson. Her extensive experience includes positions at Wrigley, General Mills, and Procter & Gamble.

Moreover, John Kelly is stepping into the role of Chief Marketing Officer after serving as vice president of consumer marketing.

Have you read?
Ranked: The World’s Most Powerful Countries For 2023.
Ranked: Countries with the highest share of women in parliament.
The World’s Largest old Producing Countries, 2023.
Ranked: The World’s Most Influential Countries, 2023.
Ranked: World’s Most Forward-Thinking Countries, 2023.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name